HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keratin-8-deficient mice develop chronic spontaneous Th2 colitis amenable to antibiotic treatment.

Abstract
Keratin 8 (K8) is the major intermediate filament protein present in intestinal epithelia. Depending on the mouse genetic background, absence of K8 causes embryonic lethality or colonic hyperplasia and colitis. We studied disease progression, the inflammatory responses, and role of luminal bacteria in K8-null mice in order to characterize the intestinal pathology of K8-associated colitis. Colon lymphocytes were isolated for analysis of their phenotype and cytokine production, and vascular and lymphocyte adhesion molecule expression in K8-/- mice of varying ages. K8-/- mice had a marked increase in TCR(beta)-positive/CD4-positive T cells infiltrating the colon lamina propria, in association with enhanced Th2 cytokine (IL-4, IL-5 and IL-13) production. K8-/- mice show early signs of inflammation even prior to weaning, that increases with age, and their epithelial cells overexpress MHC class II antigens. The chronic colitis is related to increased CD4-positive infiltrating T cells displaying memory and naive phenotypes, and an altered vascular endothelium with aberrant expression of peripheral node addressin. Analysis of normal gut-specific homing molecules, reveals an increased number of alpha(4)beta(7)-positive cells and vascular mucosal addressin cell adhesion molecule-1 in K8-null colons. Antibiotic treatment markedly decreased colon inflammation and ion transporter AE1/2 mistargeting, indicating that luminal bacteria play an important role in the observed phenotype. Therefore, K8-null mice develop chronic spontaneous Th2-type colitis due to a primary epithelial rather than immune cell defect, which is amenable to antibiotic therapy. These mice provide a model to investigate epithelial-leukocyte and epithelial-microbial cross-talk.
AuthorsAida Habtezion, Diana M Toivola, Eugene C Butcher, M Bishr Omary
JournalJournal of cell science (J Cell Sci) Vol. 118 Issue Pt 9 Pg. 1971-80 (May 01 2005) ISSN: 0021-9533 [Print] England
PMID15840656 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anti-Bacterial Agents
  • Antigens, Surface
  • CD4 Antigens
  • CD8 Antigens
  • Cell Adhesion Molecules
  • Cytokines
  • Immunoglobulins
  • Integrins
  • Interleukin-13
  • Interleukin-5
  • Ions
  • L-selectin counter-receptors
  • Madcam1 protein, mouse
  • Membrane Proteins
  • Mucoproteins
  • Receptors, Antigen, T-Cell
  • integrin alpha4beta7
  • Interleukin-4
  • Keratins
Topics
  • Animals
  • Anti-Bacterial Agents (pharmacology)
  • Antigens, Surface (biosynthesis, metabolism)
  • CD4 Antigens (biosynthesis)
  • CD4-Positive T-Lymphocytes (cytology)
  • CD8 Antigens (biosynthesis)
  • Cell Adhesion Molecules
  • Cell Membrane (metabolism)
  • Colitis (genetics, immunology)
  • Colon (immunology, pathology)
  • Cytokines (metabolism)
  • Disease Progression
  • Endothelium, Vascular (metabolism, pathology)
  • Epithelial Cells (pathology)
  • Flow Cytometry
  • Immunoglobulins (biosynthesis)
  • Immunohistochemistry
  • Inflammation
  • Integrins (biosynthesis)
  • Interleukin-13 (metabolism)
  • Interleukin-4 (metabolism)
  • Interleukin-5 (metabolism)
  • Ions
  • Keratins (chemistry, genetics, physiology)
  • Lymphocytes (cytology, metabolism)
  • Membrane Proteins (biosynthesis, metabolism)
  • Mice
  • Mice, Transgenic
  • Microscopy, Fluorescence
  • Models, Biological
  • Mucoproteins (biosynthesis)
  • Phenotype
  • Protein Structure, Tertiary
  • Receptors, Antigen, T-Cell (biosynthesis)
  • Th2 Cells (immunology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: